How are you managing patients with unfavorable intermediate-risk prostate cancer who would be eligible for RTOG 0232?
Brachytherapy monotherapy, EBRT + ADT, or tri-modality therapy? What duration of ADT would you use?
Answer from: Radiation Oncologist at Community Practice
This question came up on my Google search results of all places when looking to see if 0232 has been fully published yet (it has not). I'll provide a perspective because I think this is an important question, though I certainly appreciate those of the subspecialists, should one of them see this and ...
Answer from: Radiation Oncologist at Community Practice
LDR Brachytherapy alone can be an appropriate option for selected patients with unfavorable intermediate risk disease, depending on the expertise of the brachytherapist, pending RTOG 0232 publication with sub-group analysis to provide additional insights.
Comments
Radiation Oncologist at Jacob E Locke MD PA Relying on subgroup analysis should be done with c...